Home > Products > CD16 & MET > Anti-CD16 x Anti-MET Bispecific aptamer (DNA/DNA)

Anti-CD16 x Anti-MET Bispecific aptamer (DNA/DNA)  (CAT#: KN-0825-JL2)

Anti-CD16 x Anti-MET Bispecific aptamer (DNA/DNA) consists of an anti-CD16 DNA aptamer and an anti-MET DNA aptamer, linked by a single-stranded DNA (ssDNA) spacer. It is monovalent for each antigen specificity, 1+1 antigen-binding valency. This bispecific aptamer (BsApt) can retarget NK cells to tumor cells. It is designed for the research of Pancreatic cancer; Ovarian cancer; Breast cancer; Bile duct cancer (BDC) therapy.
Datasheet INQUIRY

Specifications

Targets
CD16 & MET
Type
Bispecific Aptamer
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Solid tumors

Targets

Target 1
CD16
Gene ID
UniProt ID
Alternative Names
FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); CD16; FCG3; CD16A; FCGR3; IGFR3; IMD20; FCR-10; FCRIII; FCGRIII; FCRIIIA; low affinity immunoglobulin gamma Fc region receptor III-A; FcγRIII; FcgammaRIIIA; CD16a antigen; fc-gamma RIII; Fc-gamma RIIIa; Fc-gamma RIII-alpha; igG Fc receptor III-2; Fc gamma receptor III-A; Fc-gamma receptor IIIb; neutrophil-specific antigen NA; Fcgamma receptor III-2; immunoglobulin G Fc receptor III; Fc fragment of IgG, low affinity III, receptor
Target 2
MET
Gene ID
UniProt ID
Alternative Names
MET; MET proto-oncogene, receptor tyrosine kinase; HGFR; AUTS9; RCCP2; c-Met; hepatocyte growth factor receptor; SF receptor; HGF receptor; HGF/SF receptor; proto-oncogene c-Met; scatter factor receptor; tyrosine-protein kinase Met; met proto-oncogene tyrosine kinase
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CD16 x Anti-MET Bispecific aptamer (DNA/DNA) (KN-0825-JL2). Click the button below to contact us or submit your feedback about this product.